(Q43829230)

English

Cis-diamminodichloroplatinum plus a 5-day continuous infusion of 5-fluorouracil in the treatment of locally recurrent and metastatic head and neck cancer patients

scientific article published in January 1989

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Cis-diamminodichloroplatinum plus a 5-day continuous infusion of 5-fluorouracil in the treatment of locally recurrent and metastatic head and neck cancer patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

head and neck cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

head and neck carcinoma

1 reference

based on heuristic

inferred from title

author name string

S Palmeri

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

V Gebbia

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

A Russo

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

N Gebbia

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

D Oliveri

5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

L Rausa

6

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

publication date

1 January 1989

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Journal of Cancer Research and Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

115

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

579-582

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

https://scigraph.springernature.com/pub.10.1007/bf00391362

0 references

Chemotherapy in head and neck cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/2606933

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized prospective comparison of methotrexate with a combination of methotrexate, bleomycin, and cisplatin in head and neck cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/2606933

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An analysis of distant metastases from squamous cell carcinoma of the upper respiratory and digestive tracts

1 reference

https://pubmed.ncbi.nlm.nih.gov/2606933

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination chemotherapy with cis-diamminedichloroplatinum, oncovin, and bleomycin (COB) in advanced head and neck cancer phase II

1 reference

https://pubmed.ncbi.nlm.nih.gov/2606933

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Head and neck cancer: chemotherapy concepts.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2606933

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of squamous-cell carcinoma of the head and neck with cisplatin and 5-fluorouracil

1 reference

https://pubmed.ncbi.nlm.nih.gov/2606933

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cisplatin and 5-fluorouracil chemotherapy in advanced or recurrent squamous cell carcinoma of the head and neck

1 reference

https://pubmed.ncbi.nlm.nih.gov/2606933

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy strategies in squamous cell carcinoma of the head and neck

1 reference

https://pubmed.ncbi.nlm.nih.gov/2606933

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized trial of cisplatin (CACP) + 5-fluorouracil (5-FU) infusion and CACP + 5-FU bolus for recurrent and advanced squamous cell carcinoma of the head and neck

1 reference

https://pubmed.ncbi.nlm.nih.gov/2606933

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination chemotherapy with methotrexate, bleomycin, and vincristine with or without cisplatin in advanced squamous cell carcinoma of the head and neck

1 reference

https://pubmed.ncbi.nlm.nih.gov/2606933

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized trial of the combination of cis-platinum, oncovin and bleomycin (COB) versus methotrexate in patients with advanced squamous cell carcinoma of the head and neck

1 reference

https://pubmed.ncbi.nlm.nih.gov/2606933

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective evaluation of 5-fluorouracil plus cisplatin in advanced squamous-cell cancer of the head and neck.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2606933

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120-hour 5-FU infusion and cisplatin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2606933

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Advanced recurrent squamous cell carcinoma of the head and neck. Results of a chemotherapeutic regimen with adriamycin, bleomycin, 5-fluorouracil, methotrexate, and vitamin A

1 reference

https://pubmed.ncbi.nlm.nih.gov/2606933

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy of advanced head and neck cancer with methotrexate, bleomycin, and cis-diamminedichloroplatinum II in an effective outpatient schedule

1 reference

https://pubmed.ncbi.nlm.nih.gov/2606933

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sequential combination chemotherapy for advanced squamous cell carcinoma of the head and neck

1 reference

https://pubmed.ncbi.nlm.nih.gov/2606933

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cisplatin and 5-fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck

1 reference

https://pubmed.ncbi.nlm.nih.gov/2606933

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factors that affect response to chemotherapy and survival of patients with advanced head and neck cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/2606933

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00391362

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43829230&oldid=2103709198"